CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach
PurposeGlioma remains a lethal malignancy with limited prognostic biomarkers. This study evaluates the prognostic significance and functional mechanisms of tetraspanin CD9 in glioma to establish its clinical relevance and identify therapeutic strategies.MethodsMulti-omics analyses were performed usi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1507443/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850190531733225472 |
|---|---|
| author | Yue Peng Qiang Ji Qiang Ji Xiangyu Guo Weichunbai Zhang Zixuan Yang Wenbin Li Wenbin Li |
| author_facet | Yue Peng Qiang Ji Qiang Ji Xiangyu Guo Weichunbai Zhang Zixuan Yang Wenbin Li Wenbin Li |
| author_sort | Yue Peng |
| collection | DOAJ |
| description | PurposeGlioma remains a lethal malignancy with limited prognostic biomarkers. This study evaluates the prognostic significance and functional mechanisms of tetraspanin CD9 in glioma to establish its clinical relevance and identify therapeutic strategies.MethodsMulti-omics analyses were performed using 1,033 glioma samples from TCGA and CGGA cohorts. A CD9-integrated nomogram was developed via Cox regression. Two-sample Mendelian randomization (MR) assessed the causal link between CD9 expression and glioma risk using IVW, MR-Egger, and WM methods. KEGG enrichment analysis identified biological pathways. Single-cell RNA sequencing from 20 glioblastoma cases was analyzed using CellChat and Monocle3 to explore CD9-mediated cell communication and lineage transitions. Protein-protein interaction (PPI) networks were constructed via STRING and GeneMANIA, and drug predictions were performed using DsigDB.ResultsCD9 overexpression was an independent predictor of poor survival (HR = 1.28, 95% CI 1.03–1.58). The CD9-based nomogram showed high prognostic accuracy (CGGA: C-index = 0.805 ± 0.01, TCGA: C-index = 0.859 ± 0.02). MR confirmed a causal association between CD9 and glioma risk (IVW OR = 1.33, p < 0.05) with no horizontal pleiotropy. CD9 regulated glioma progression via calcium signaling and synaptic pathways, interacting with ITGB1 and CD81. Single-cell analysis revealed CD9-driven NPC-to-OPC transdifferentiation, linked to tumor proliferation. Emetine was identified as a potential CD9-targeting drug.ConclusionCD9 is a prognostic biomarker in glioma, with causal evidence linking its overexpression to tumor development. Its integration into risk models enhances prognostic precision, while drug screening highlights emetine as a potential therapy. |
| format | Article |
| id | doaj-art-ea406cce4ca84c808f01445dcd327db8 |
| institution | OA Journals |
| issn | 1664-2295 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj-art-ea406cce4ca84c808f01445dcd327db82025-08-20T02:15:15ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-04-011610.3389/fneur.2025.15074431507443CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approachYue Peng0Qiang Ji1Qiang Ji2Xiangyu Guo3Weichunbai Zhang4Zixuan Yang5Wenbin Li6Wenbin Li7Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNational Institute for Data Science in Health and Medicine, Capital Medical University, Beijing, ChinaNational Institute for Data Science in Health and Medicine, Capital Medical University, Beijing, ChinaNational Institute for Data Science in Health and Medicine, Capital Medical University, Beijing, ChinaNational Institute for Data Science in Health and Medicine, Capital Medical University, Beijing, ChinaDepartment of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaNational Institute for Data Science in Health and Medicine, Capital Medical University, Beijing, ChinaPurposeGlioma remains a lethal malignancy with limited prognostic biomarkers. This study evaluates the prognostic significance and functional mechanisms of tetraspanin CD9 in glioma to establish its clinical relevance and identify therapeutic strategies.MethodsMulti-omics analyses were performed using 1,033 glioma samples from TCGA and CGGA cohorts. A CD9-integrated nomogram was developed via Cox regression. Two-sample Mendelian randomization (MR) assessed the causal link between CD9 expression and glioma risk using IVW, MR-Egger, and WM methods. KEGG enrichment analysis identified biological pathways. Single-cell RNA sequencing from 20 glioblastoma cases was analyzed using CellChat and Monocle3 to explore CD9-mediated cell communication and lineage transitions. Protein-protein interaction (PPI) networks were constructed via STRING and GeneMANIA, and drug predictions were performed using DsigDB.ResultsCD9 overexpression was an independent predictor of poor survival (HR = 1.28, 95% CI 1.03–1.58). The CD9-based nomogram showed high prognostic accuracy (CGGA: C-index = 0.805 ± 0.01, TCGA: C-index = 0.859 ± 0.02). MR confirmed a causal association between CD9 and glioma risk (IVW OR = 1.33, p < 0.05) with no horizontal pleiotropy. CD9 regulated glioma progression via calcium signaling and synaptic pathways, interacting with ITGB1 and CD81. Single-cell analysis revealed CD9-driven NPC-to-OPC transdifferentiation, linked to tumor proliferation. Emetine was identified as a potential CD9-targeting drug.ConclusionCD9 is a prognostic biomarker in glioma, with causal evidence linking its overexpression to tumor development. Its integration into risk models enhances prognostic precision, while drug screening highlights emetine as a potential therapy.https://www.frontiersin.org/articles/10.3389/fneur.2025.1507443/fullGliomaCD9Cox proportional hazards regressionMendelian randomizationSingle-cell analysis |
| spellingShingle | Yue Peng Qiang Ji Qiang Ji Xiangyu Guo Weichunbai Zhang Zixuan Yang Wenbin Li Wenbin Li CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach Frontiers in Neurology Glioma CD9 Cox proportional hazards regression Mendelian randomization Single-cell analysis |
| title | CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach |
| title_full | CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach |
| title_fullStr | CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach |
| title_full_unstemmed | CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach |
| title_short | CD9 expression rivals IDH mutation as a prognostic marker in glioma: a novel nomogram approach |
| title_sort | cd9 expression rivals idh mutation as a prognostic marker in glioma a novel nomogram approach |
| topic | Glioma CD9 Cox proportional hazards regression Mendelian randomization Single-cell analysis |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2025.1507443/full |
| work_keys_str_mv | AT yuepeng cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT qiangji cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT qiangji cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT xiangyuguo cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT weichunbaizhang cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT zixuanyang cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT wenbinli cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach AT wenbinli cd9expressionrivalsidhmutationasaprognosticmarkeringliomaanovelnomogramapproach |